Environmental Health

PFAS Chemistry, Classification, and Why They Persist as Forever Chemicals

OECD 2021 structural definition, long- vs short-chain classes, C–F bond strength, and multi-year serum half-lives—not infinite, but extreme.

BY ELENA VOSS 4 MIN READ 3 SOURCES

Molecular model of fluorinated carbon chain beside water glass and lab notebook, no people — Illustration: Health Canon

In short

PFAS share extreme C–F persistence. OECD 2021: ≥1 fully fluorinated CF₃/CF₂ carbon. Long-chain species (PFOA/PFOS/PFHxS) have multi-year serum half-lives; short-chain are more mobile. Forever in the environment ≠ infinite body retention.

Calling PFAS forever chemicals is useful science communication for environmental persistence—and sloppy if it implies infinite human half-lives or identical toxicity for every fluorinated structure. Chemistry and chain length set the risk map.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

What is the structural definition of PFAS?

OECD 2021 reconciles competing lists into a structural rule: at least one fully fluorinated methyl or methylene carbon.

Class inventories under broad definitions span thousands to more than ten thousand discrete structures—ECHA restriction framing uses that scale.

Perfluoroalkyl species are fully fluorinated along the chain; polyfluoroalkyl species are partially fluorinated and often act as precursors to terminal acids.

How do long-chain and short-chain PFAS differ in the body and environment?

Long-chain PFOA/PFOS/PFHxS show multi-year human elimination half-lives with active renal reabsorption and protein binding.

Short-chain homologues generally clear faster from serum but are highly water-mobile and environmentally persistent.

Precursors (fluorotelomers, side-chain polymers) can transform into persistent terminal acids—monitoring only a short acid panel undercounts total fluorine burden.

Key reference points
Class feature	Long-chain example	Short-chain note
Serum half-life	Years (PFOA/PFOS)	Days–weeks often
Water mobility	Sorb more; still plumes	Highly mobile
Treatment	GAC often better	Earlier breakthrough
Regulation trend	MCLs + bans	Class restrictions expand

What quantitative half-life ranges matter for readers?

ATSDR ToxGuide-class ranges: PFOA about 2.1–10.1 years; PFOS 3.3–27 years; PFHxS 4.7–35 years; PFNA roughly 2.5–4.3 years; short-chain PFBA on the order of hours to days.

Li et al. 2018 Ronneby means after water remediation: PFOA ~2.7 y, PFOS ~3.4 y, PFHxS ~5.3 y.

Rodent half-lives are shorter—never paste animal TK numbers into human risk talk without scaling.

What anti-patterns should editors avoid?

Equating PFOA-free labels with OECD-class PFAS absence; conflating all PFAS toxicity with PFOA/PFOS; claiming chemicals never leave the body; ignoring precursors when only terminal acids are measured.

Sources: OECD PFAS definition (ES&T 2021); ATSDR ToxProfile Perfluoroalkyls; ATSDR ToxGuide half-lives.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims.

Sources & citations

Frequently asked

Questions & answers

What makes a chemical a PFAS under the OECD 2021 definition?

OECD 2021 defines PFAS as fluorinated substances with at least one fully fluorinated methyl (–CF₃) or methylene (–CF₂–) carbon without hydrogen or halogen substitution on that carbon. That structural criterion captures thousands of substances—not only legacy PFOA and PFOS. Regulators increasingly use the class definition to prevent narrow substitutions that keep the C–F core. Brand names and marketing labels are not classification systems.

Do forever chemicals stay in the body forever?

No. Environmental persistence is extreme because the C–F bond resists hydrolysis, photolysis, and most biological attack. Human serum elimination still occurs over years for long-chain PFAS—ATSDR ranges include roughly 2–10 years for PFOA and longer multi-year ranges for PFOS and PFHxS—not infinite retention. Short-chain species often clear in days to weeks from serum while remaining environmentally mobile.

What is long-chain versus short-chain PFAS?

Historical EPA/OECD convention treats PFCAs with ≥8 carbons (e.g., PFOA) and PFSAs with ≥6 carbons (e.g., PFOS, PFHxS) as long-chain, with shorter homologues as short-chain. Long-chain compounds generally bioaccumulate more in humans; short-chain replacements often break through water treatment earlier and travel farther in aquifers. Neither class is automatically safe.

Why do short-chain replacements still matter?

Phase-outs of long-chain chemistry often led to ether-PFAS or shorter chains (e.g., GenX/HFPO-DA) that retain C–F persistence—the classic regrettable substitution pattern. Mobility in drinking water can increase community exposure even when serum half-lives shorten. Class-based regulation and treatment design must account for that tradeoff.

How should PFAS be biomonitored?

PFAS bind serum albumin and liver proteins rather than classic adipose fat stores, so blood (serum/plasma) panels—not fat biopsies—are the standard body-burden tool. Targeted LC-MS/MS panels of terminal acids can miss precursors; total organic fluorine or TOP assays add breadth when indicated. Units: serum ng/mL (ppb) versus water ng/L (ppt)—never mix systems.